Practice Management

Women remain underrepresented in cardiology despite a growing pipeline of female medical students and internal medicine resident physicians, according to a Sept. 11 report in JAMA Cardiology.

Chicago biotech company BIOLIFE4D announced this week it had successfully 3D-bioprinted a mini human heart—something the company noted as a “significant milestone” on the path to printing full-sized hearts viable for transplant.

Proven protocols and practices, people and a push for earlier hemodynamic support are changing the face of cardiogenic shock survival. One leading health system has improved survival rates into the 70+ percent range. And their team believes other facilities should follow suit.

The level of pragmatism in CV-related randomized clinical trials has only increased moderately over the past two decades, according to work published in JAMA Cardiology Sept. 1.

Research presented this month at the ESC Congress in Paris suggests that getting a yearly influenza shot could greatly cut hypertensive patients’ risk of dying during flu season.

Research out of the Netherlands suggests current clinical guidelines might recommend overtreatment for women with heart failure, who see maximum benefit from HF drugs at half the dose of men.

Malpractice litigation is a risk that’s inherent to acute stroke care, Mount Sinai researchers reported in Stroke this month—and while just over half of cases get resolved, the remainder can cost medical centers millions in payouts.

A team of researchers in Iran, the U.S. and the U.K. may have cracked the code of the elusive polypill, they reported after finding their four-drug concoction effectively reduced adverse CV events in nearly 3,500 patients.

Advances in diabetes care over the past decade haven’t translated into better patient outcomes, researchers at Massachusetts General Hospital have found, with just one in four U.S. adults with the disease meeting treatment goals between 2005 and 2016.

A combination of 107 chest compressions per minute at a depth of 4.7 centimeters is the optimal CCR-CCD (chest compression rate-chest compression depth) ratio for survival after an out-of-hospital cardiac arrest, researchers reported August 14 in JAMA Cardiology.

Researchers on the International Space Station are leveraging the microgravity conditions within the ISS U.S. National Laboratory to study heart cells in ways we can’t on the ground.

The results of a Journal of Cardiovascular Nursing study suggest motivation is the key driver of adherence to secondary prevention measures among women who have CHD and have undergone PCI.